Elevated LDL Cholesterol
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
FerrerSpain - Barcelona
2 programs2
Cardiovascular fixed dose combination pillPhase 21 trial
Cardiovascular fixed dose combination pillPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
FerrerCardiovascular fixed dose combination pill
FerrerCardiovascular fixed dose combination pill
Clinical Trials (2)
Total enrollment: 143 patients across 2 trials
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Start: Oct 2010Est. completion: Apr 2012107 patients
Phase 2Terminated
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
Start: Sep 2009Est. completion: Mar 201136 patients
Phase 2Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.